v3.25.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Level 3 Investments
The table below presents activity within Level 3 of the fair value hierarchy, our liabilities carried at fair value relating to the medac settlement, for the six months ended June 30, 2025:
Level 3
(In thousands)Contingent
liabilities
Balance at January 1, 2025$974 
Change due to liability payment(208)
Liability fair value adjustment(56)
Total change in foreign exchange92 
Balance at June 30, 2025$802 
Schedule of Financial Assets and Liabilities Measured at Fair Value
The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value as of June 30, 2025 and December 31, 2024 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value.
June 30, 2025
(In thousands)Quoted Prices in
Active Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Money market funds$$— $— $
U.S. government agency bonds— 46,584 — 46,584 
Total Assets$$46,584 $— $46,592 
Liabilities:
Contingent Liability$— $— $802 $802 
Total Liabilities$— $— $802 $802 
December 31, 2024
(In thousands)Quoted Prices in
Active Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Money market funds$$— $— $
U.S. government agency bonds— 20,821 — 20,821 
Total Assets$$20,821 $— $20,830 
Liabilities:
Contingent Liability$— $— $974 $974 
Total Liabilities$— $— $974 $974